Compounds > indazoles
Page last updated: 2024-08-21

indazoles and buparlisib

indazoles has been researched along with buparlisib in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bergling, S; Blommers, MJ; Brachmann, SM; Brümmendorf, T; Fritsch, C; Garcia-Echeverria, C; Gaulis, S; Guthy, DA; Hattenberger, M; Henry, C; Hofmann, F; Kauffmann, A; Kazic-Legueux, M; Kleylein-Sohn, J; Laborde, L; Maira, SM; Murakami, M; Romanet, V; Sellers, WR; Stauffer, F; Sterker, D; Vaxelaire, J; Wilson, C1
Dan, S; Kong, D; Yamazaki, K; Yamori, T1
Bonazzi, VF; Cummings, MC; Geng, X; Ju, RJ; Mahon, CE; Packer, LM; Pollock, PM; Stephenson, SA1

Other Studies

3 other study(ies) available for indazoles and buparlisib

ArticleYear
Characterization of the mechanism of action of the pan class I PI3K inhibitor NVP-BKM120 across a broad range of concentrations.
    Molecular cancer therapeutics, 2012, Volume: 11, Issue:8

    Topics: Aminopyridines; Animals; Cell Cycle Checkpoints; Cell Line, Tumor; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Indazoles; Mice; Mitosis; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Protein Multimerization; Rats; Sulfonamides; Tubulin

2012
In vitro multifaceted activities of a specific group of novel phosphatidylinositol 3-kinase inhibitors on hotspot mutant PIK3CA.
    Investigational new drugs, 2014, Volume: 32, Issue:6

    Topics: Aminopyridines; Antineoplastic Agents; Caspase 3; Caspase 7; Cell Line, Tumor; Cell Proliferation; Class I Phosphatidylinositol 3-Kinases; Humans; Imidazoles; Indazoles; Morpholines; Mutation; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; Quinolines; Sulfonamides; Triazines

2014
PI3K Inhibitors Synergize with FGFR Inhibitors to Enhance Antitumor Responses in FGFR2
    Molecular cancer therapeutics, 2017, Volume: 16, Issue:4

    Topics: Aminopyridines; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Indazoles; Mice; Morpholines; Mutation; Phenylurea Compounds; Phosphoinositide-3 Kinase Inhibitors; Pyrimidines; Receptor, Fibroblast Growth Factor, Type 2; Sulfonamides; Thiazoles; Xenograft Model Antitumor Assays

2017